The conserved carboxyl terminus of human parainfluenza virus type 2 V protein plays an important role in virus growth  by Nishio, Machiko et al.
07) 85–98
www.elsevier.com/locate/yviroVirology 362 (20The conserved carboxyl terminus of human parainfluenza virus type 2 V
protein plays an important role in virus growth
Machiko Nishio a,⁎, Masato Tsurudome a, Hisamitsu Ishihara b, Morihiro Ito c, Yasuhiko Ito c
a Department of Microbiology, Mie University Graduate School of Medicine, 2-174, Edobashi, Tsu, Mie, 514-8507, Japan
b Division of Molecular Metabolism and Diabetes, Tohoku University Graduate School of Medicine, Sendai, Miyagi, 980-8575, Japan
c Department of Microbiology, College of Life and Health Sciences, Chubu University, Kasugai, Aichi, 487-8501, Japan
Received 21 September 2006; returned to author for revision 18 October 2006; accepted 18 December 2006
Available online 23 January 2007Abstract
Our previous results have shown that some residues of V protein-specific domain in human parainfluenza virus type 2 (hPIV2) are essential not
only for STAT protein degradation but also for promoting virus growth. Here, we demonstrated that the virus growth of these recombinant hPIV2s
(rPIV2) expressing mutated V proteins were improved in HeLa cell transiently expressing the wild-type V protein, but not in the cells
constitutively expressing it. Consequently, we identified the region of the V protein that is essential for its oligomerization and for complex
formation with NP protein. We also identified a host protein, AlP1/Alix, involved in apoptosis and efficient budding of several enveloped viruses
as an interacting partner of the V and NP proteins. Depletion of AIP1/Alix by small interfering RNA suppressed virus growth. These data suggest
that the conserved carboxyl terminus of the V protein plays an important role in virus growth.
© 2006 Elsevier Inc. All rights reserved.Keywords: Human parainfluenza virus type 2; V protein; Virus growthIntroduction
Human parainfluenza virus type 2 (hPIV2) is a member of
the Rubulavirus genus of the family Paramyxoviridae. The
Paramyxoviridae family includes many well-known human and
animal pathogens, such as Sendai virus (SeV), human
parainfluenza viruses (hPIV) type 1–4, simian virus 5 (SV5),
mumps virus (MuV), Newcastle disease virus (NDV), measles
virus (MV), and respiratory syncytial virus, as well as important
emerging viruses such as Hendra and Nipah viruses. The
negative-stranded RNA genome of hPIV2 is 15,654 nucleotides
long and encodes seven viral proteins from six genes (Lamb and
Kolakofsky, 2001). The nucleocapsid protein (NP), phospho-
protein (P), and large RNA polymerase (L) protein are
important for transcription and replication of the viral RNA⁎ Corresponding author. Fax: +81 59 231 5008.
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doi:10.1016/j.virol.2006.12.017genome. The fusion (F) protein and the hemagglutinin-
neuraminidase (HN) protein are transmembrane glycoproteins.
The matrix (M) protein plays an important role in virus
assembly.
The hPIV2 V mRNA is a faithful transcript of the V/P gene,
whereas the P mRNA is synthesized through a cotranscriptional
RNA editing process in which two nontemplated G residues are
inserted into the templated mRNA transcript. Therefore, the N-
terminal 164 amino acids (aa) of the V and P proteins are
common, while their C-termini are unique (Ohgimoto et al.,
1990). The C-terminus of hPIV2 V protein contains seven
invariant cysteine residues capable of binding two atoms of zinc
and approximately 50% identical among all paramyxovirus V
proteins. The hPIV2 V protein is incorporated into virions, as is
the case in SV5, MuV, and NDV, while those of SeVandMVare
not (Lamb and Kolakofsky, 2001; Mebatsion et al., 2001;
Paterson et al., 1995; Takeuchi et al., 1990; Valsamakis et al.,
1998).
The hPIV2 V protein appears to be a multifunctional protein.
The V protein interacts with the NP and the NP-binding region
has been mapped to the N-terminal 47 amino acids (aa), which
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al., 1996b). On the other hand, the V protein has two
noncontiguous regions, aa 1–46 and aa 175–196, that are
required for nuclear localization and retention (Watanabe et al.,
1996a). Therefore, it shows diffuse nuclear and cytoplasmic
distribution in virus-infected cells. In contrast, as the P protein
has two independent NP-binding sites, aa 1–46 and aa 357–
395, and a P-multimerization domain, aa 211–248, it is
organized in numerous granules with the NP protein in the
cytoplasm of virus-infected cells. The difference in the
subcellular distribution is due to the binding between residues
357–395 on the C-terminal domain of the P protein and residues
295–402 on the NP protein (Nishio et al., 1996, 1997, 1999b). It
is presumed that the P protein forms a complex with both
unassembled NP (soluble NP, NP0) and assembled NP (NP in
helical nucleocapsids, NPNC), but the V protein forms a
complex only with NP0 in the case of SeV and SV5 V proteins
(Horikami et al., 1996; Randall and Bermingham, 1996). The
hPIV2 V protein also binds to viral RNA via its RNA-binding
regions, aa 1–82 (P/V common domain) and aa 176–225
(Nishio et al., 2006).
It has recently been demonstrated that viruses of the Para-
myxoviridae, similar to other viruses, have evolved specific
proteins that inhibit interferon (IFN)-induced innate antiviral
responses through direct inhibition of cellular STAT proteins.
The V proteins encoded by the rubulaviruses, SV5, simian virus
41 (SV41), and MuV, and an avulavirus, NDV, block IFN
signaling by targeting STAT1 for degradation (Andrejeva et al.,
2002; Didcock et al., 1999a, 1999b; Huang et al., 2003; Kubota
et al., 2001; Nishio et al., 2001, 2005b; Park et al., 2003; Ulane
and Horvath, 2002; Ulane et al., 2003; Yokosawa et al., 2002;
Young et al., 2000), whereas the V protein of hPIV2 targets
STAT2 for degradation (Nishio et al., 2001, 2005b; Parisien et
al., 2001). The V proteins of MV (a morbillivirus), Nipah, and
Hendra viruses (henipaviruses) have been shown to inhibit IFN
signaling by preventing STAT1 and STAT2 nuclear accumula-
tion (Palosaari et al., 2003; Rodriguez et al., 2002, 2003;
Takeuchi et al., 2003). SeV and hPIV3 (respiroviruses) also
block IFN signaling, and this anti-IFN ability has been shown to
be a property of their C proteins (Garcin et al., 1999, 2000,
2002; Gotoh et al., 1999, 2003; Kato et al., 2001; Komatsu et
al., 2000; Malur et al., 2005; Takeuchi et al., 2001). The
rubulavirus V protein-dependent degradation of STAT proteins
involves degradation complexes that contain the V protein,
STAT1, and STAT2 (and STAT3 in the case of MuV). A number
of cellular proteins, including the UV-damaged DNA-binding
protein (DDB) 1 and Cullin4A (Cul4A) that are subunits of an
SCF-type ubiquitin ligase (Ulane and Horvath, 2002) are also
required. The conserved seven cysteine residues of the V
protein play a critical role in its specific binding to DDB1
(Andrejeva et al., 2002; Lin et al., 1998). On the other hand, the
binding between the V and STAT proteins occurs via
tryptophan-rich motif that lies just upstream of the cysteine
cluster at the C-terminus, and the cysteine residues are not
required for this binding (Nishio et al., 2002). The only
paramyxovirus that cannot evade the IFN-induced antiviral
responses to data is hPIV4, although it has the V protein, with ahighly conserved cycteine-rich domain and tryptophan-rich
motif, that binds STAT1, STAT2, DDB1, and Cullin4A (Nishio
et al., 2005a). The mechanism of STAT lowering induced by
rubulavirus has not clearly been understood yet.
Recombinant morbilliviruses (Schneider et al., 1997),
respiroviruses (Delenda et al., 1997; Kato et al., 1997), and an
avulavirus (Huang et al., 2003; Park et al., 2003) that cannot
express their V and W proteins have been recovered, and all
these viruses grow similarly to the respective parent virus at
least in some cell lines, such as Vero cells. In contrast to V-
minus viruses of these other paramyxovirus genera, we
previously demonstrated that the V-minus hPIV2 is highly
debilitated and that its growth is very limited even in Vero cells.
Recombinant SV5VΔC that lacks the C-terminal V protein-
specific domain grows well in Vero cells similarly to parent
SV5. However, we also demonstrated that the virus yields of
rPIV2VΔC and rPIV2s carrying mutations in the C-terminal V
protein-specific domain are two to three orders of magnitude
lower than that of wild-type (wt) hPIV2 even in Vero cells
(Kawano et al., 2001; Nishio et al., 2005b). The hPIV2 V
protein is thus clearly important for promoting virus growth,
independent of the anti-IFN activity.
In this study, we investigated whether the virus growth of
recombinant hPIV2s (rPIV2) with mutant V proteins would
improve in HeLa cells expressing the V protein. Unfortunately,
the growth of these rPIV2s did not improve in HeLa cells
constitutively expressing the V protein (HeLa-V). However,
we demonstrated the improvement of the virus growth in HeLa
cells transiently expressing the V protein. As the distribution
of viral proteins in the cells infected with these rPIV2s
carrying mutations in the V protein-specific domain was
different from that in parent hPIV2-infected cells, we searched
for the binding partners of V protein and identified that the C-
terminus of the V protein was essential for its oligomerization
and for complex formation with NP protein. We have also
identified a host protein, AlP1/Alix, involved in apoptosis and
efficient budding of several enveloped viruses, as an interact-
ing partner of the V protein. These data suggest that the
conserved carboxyl terminus of V protein plays an important
role in virus growth.
Results
Growth of various rPIV2s with mutant V proteins in the
IFN-unresponsive cell lines
In a previous report, we identified hPIV2 V protein residues
essential for STAT2 protein degradation in human cell lines that
are conserved seven cysteine residues (193,197, 209, 211, 214,
218, and 221 Cys), three tryptophan residues (178, 182, and 192
Trp), a phenylalanine residue (207 Phe) in the C-terminal V-
unique domain, and 143 Phe in the P/V common domain. These
residues in the V-specific domain that are essential for anti-IFN
activity are also essential for promoting virus growth (Nishio et
al., 2005b). To confirm the relationship between the virus
growth and IFN response, the growth of the recombinant
hPIV2s (rPIV2) carrying mutant V protein in the V-specific
Fig. 1. Growth kinetics of rPIV2s carrying V protein mutations in the IFN-unresponsive cell lines. Monolayers of 2fTGH, U3A (STAT1 deficient), and U6A (STAT2
deficient) cells were infected with the various rPIV2s (A) at an MOI of ca. 0.1. Samples of the supernatants were harvested at various times postinfection, and their
titers (Log TCID50/ml) were determined by CPE methods on Vero cells (B). The amino acids are numbered from the N-terminus of the V protein.
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compared to that in the parental cell line. The U3A and U6A cell
lines are defective for STAT1 or STAT2 expression respectively
(Leung et al., 1995; McKendry et al., 1991; Muller et al., 1993).
The 2fTGH cell line is the parent of the IFN-unresponsive
daughter cell lines (Pellegrini et al., 1989). Virus growth rates of
parent rPIV2 in 2fTGH, U3A, and U6A cells are similar. In
contrast, the growth rates of mutant rPIV2s are about two to
three orders of magnitude lower than those of parent rPIV2 even
in U3A or U6A cells (Fig. 1B), showing that both the Typ motif
and the Cys cluster are important for the V protein to promote
virus growth in an IFN-independent manner.
Growth of various rPIV2s with mutant V proteins in the HeLa
cell lines expressing the V protein
Subsequently, we performed a complementation assay to
examine whether the constitutive expression of the V protein
would enhance the growth of the mutant rPIV2s. The HeLa-V
cell line is derived from the HeLa cells and constitutively
expressing the hPIV2 V protein (Nishio et al., 2001). Virus
yields of parent rPIV2 in HeLa and HeLa-V cells at 48 h
postinfection were similar. However, the yields of mutant
rPIV2s were about three orders of magnitude lower than that of
parent rPIV2 even in these HeLa-V cells (Fig. 2A). These
results demonstrated that the constitutive expression of the V
protein could not improve the growth of the mutant rPIV2s.
Since the constitutively expressed V protein has no effect on
the virus growth, we next generated a stable HeLa tet-on cellline harboring a doxcycline (Dox)-inducible hPIV2 V cDNA
(HeLa-tet/V) as described in Materials and methods. As shown
in Fig. 2B, the V protein was detected by Western blotting after
appropriate stimulation with 5 μg/ml Dox. The amount of the V
protein in the HeLa-tet/V cells cultured for 2 h in the presence of
Dox is similar to that in the HeLa cells at 15 h postinfection. The
virus yields of mutant rPIV2s in HeLa-tet/V cells treated with
Dox simultaneously or at 14 h postinfection improved 10 to
100-fold than those in the nontreated cells (Fig. 2C). The virus
yields in the cells treated with Dox at 14 h postinfection were
significantly higher than those in the cells simultaneously
treated with Dox (Fig. 2C). These results indicate that the
transiently expressed V protein has an ability to promote virus
growth.
To investigate whether other V proteins of rubulaviruses have
the same ability, we established the HeLa tet-on cell lines
harboring Dox-inducible HA-tagged V cDNAs of hPIV2, SV41,
SV5, and MuV (Fig. 3A). As described above, the virus yields
were measured in these tet-on HA-tagged V protein-expressing
cell lines. As shown in Figs. 3B–E, the SV41V protein exhibited
an ability to promote hPIV2 growth like the hPIV2 V protein,
while SV5 and MuV V proteins did not.
Mapping of the domains on the V and NP proteins required for
V–NP interaction
In previous studies, we identified a domain on the V protein
of hPIV2 responsible for binding to the NP; that is, amino acid
residues 1–46 of the P/V common region are required for
Fig. 3. Virus growth of rPIV2s in HeLa-tet cell lines, in which various HA-
tagged V proteins are induced by treatment with Dox. (A) HeLa-tet cell lines
harboring Dox-inducible various HA-tagged V cDNA were treated for 24 h
with/without 5 μg/ml Dox. Total protein extracts were probed by Western blots
using anti-HA mAb. Actin was used as a loading control. (B–E) Virus growth of
rPIV2s in HeLa-tet/HA-PIV2V (B), HeLa-tet/HA-SV41 (C), HeLa-tet/HA-SV5
(D), and HeLa-tet/HA-MuV (E) cells treated with/without 5 μg/ml Dox at 48 h
postinfection. Lane 1; parent rPIV2, lane 2; rPIV2-V-W178H/W182E, lane 3;
rPIV2-V-C193/197A, and lane 4; rPIV2-V-C209/211/214A at anMOI of ca. 0.1.
Virus titers were determined as described in the legend for Fig. 1B.
Fig. 2. Virus growth of rPIV2 carrying V protein mutations in the HeLa cell
lines, in which hPIV2 V protein is expressed constitutively or induced by Dox-
inducible manner. (A) Virus growth of parent rPIV2, rPIV2-V-W178H/W182E,
-C193/197A, or -C209/211/214A in HeLa cells or HeLa-V cells, which are a cell
line constitutively expressing hPIV2 V protein. Forty-eight hours postinfection,
supernatant was harvested and used for virus titration. Virus titers were
determined as described in the legend for Fig. 1B. (B) HeLa-tet/V cells, which
are a cell line harboring Dox-inducible hPIV2 V cDNA, were treated for various
times with 5 μg/ml Dox (left panel). HeLa cells infected parent rPIV2 at an MOI
of 2 were harvested at various times (right panel). Total protein extracts were
probed by Western blots using anti-P/V mAb. Actin was used as a loading
control. (C) Virus growth of parent rPIV2, rPIV2-V-W178H/W182E, -C193/
197A, or -C209/211/214A in HeLa-tet/V cells treated with/without 5 μg/ml Dox
at 48 h postinfection. Virus titers were determined as described in the legend for
Fig. 1B.
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1999b; Watanabe et al., 1996b). The NP and P protein in rPIV2
wt-infected cells showed fine and numerous granules, but these
proteins in the cells infected with rPIV2s that have mutations in
the V-specific region distributed diffusely and some masses of
these proteins were found (data not shown). It has been
suggested that the V protein keeps NP soluble prior to
encapsidation in the SV5 system (Precious et al., 1995).
Therefore, it is presumed that the C-terminal region of V protein
has another binding domain to other virus protein(s) and a role
in keeping NP soluble. To identify the putative binding domain
in addition to that in the N-terminal region of the V protein, N-
terminally truncated V protein, V83-225, and NP were
expressed in bacterial cells and purified as described in
Materials and methods. The mixture of V83-225 protein and
NP was immunoprecipitated with anti-NP monoclonal antibody
(mAb) 20A or anti-P/V mAb 85A (this mAb react with aa 115–154 on the P/V common domain) and then the immunopreci-
pitates were analyzed by Western blot assay. As shown in Fig.
4B (right panel, line 1), the complex of NP and V83-225 was
detected in the immunoprecipitates with either anti-NP or anti-
P/V antibody. Since both the N- and C-terminally truncated V
protein, V83-175, could not make the complex (Fig. 4B, lane 2),
the C-terminal 50 amino acids of V protein seemed essential for
the V–NP complex formation. To identify the amino acid
essential for the complex formation, four mutants were
constructed in the V83-225 background as illustrated in Fig.
4A, 3–6. The complex of NP and V83-225/W178E/W182E
(Trp-motif mutant) was not detected by anti-NP mAb or anti-P/
V mAb (Fig. 4B, lane 3). However, the internally deleted
mutant V83-225/Δ155–192 that does not have the Trp-motif
could make a complex with NP protein, although the amount of
complex immunoprecipitated with anti-P/V mAb was fewer
(Fig. 4B, lane 6). The mutants of Cys-motif, V83-225/C193/
197A and V83-225/C209/211/214A, could make the complex,
but these immunoprecipitates with anti-P/V mAb were also
Fig. 4. Analysis of interactions between V and NP proteins by immunoprecipitation and Western blot assay. (A) Schematic diagram of the V proteins. The asterisks
indicate the position of the mutation residues of Trp-motif. The closed squares indicate the position of the mutation residues of Cys-motif. The arrow above marks the
editing site. Binding with NP protein is summarized on the right panel. (B) Western blot analysis of the purified proteins from transfected E. coli cells (input of
proteins, left panel) and of the proteins from immunoprecipitates using anti-P/V (upper, right panel) or anti-NP (lower, right panel) mAb. Numbers on the top of the
figure correspond to the V proteins as described in A. The asterisk on the right indicates the immunoglobulin light chain. (C) Schematic diagram of the NP proteins.
Binding with V83-225 protein is summarized on the right panel. (D) Western blot analysis of the purified proteins from transfected E. coli cells (input of proteins, left
panel) and of the proteins from immunoprecipitates using anti-NP mAbs (right panel, lanes 1, 3, and 4: anti-NP mAb 366-1, lanes 2 and 5: anti-NP mAb 159-1).
Numbers on the top of the figure correspond to the NP proteins as described in C. The asterisk on the right indicates the immunoglobulin light chain.
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immunoprecipitation studies summarized in Fig. 4A indicate
that the C-terminal 50 amino acids on the V protein is essential
for its binding with NP protein and that conserved Cys-motif
and Trp-motif are also important. Especially, it is speculated that
the mutation of Trp-motif on the V protein may alter the
conformation of the V protein.
Next, we intended to determine the domain on the NP that
would be responsible for its binding to the C-terminus of the V
protein by using the similar method as described above. Various
truncated NPs as illustrated in Fig. 4C were mixed with V83-
225 and then the mixtures were immunoprecipitated with anti-
NP mAbs (Fig. 4D). As shown Figs. 4C and D, V83-225 and
the truncated NPs containing the N-terminal 82 amino acids
were co-immunoprecipitated.Thus, as summarized in Figs. 4A and C, the C-terminal 50
amino acids on the V protein are important for its binding to the
N-terminal 82 amino acids on the NP.
Oligomerization of the V protein
To examine the possible interaction between the V and P
proteins, the Flag-tagged V protein and non-tagged P protein
were coexpressed in COS cells and the cell lysates were
immunoprecipitated by anti-Flag mAb as described in
Materials and methods. As shown in Fig. 5B, lane 6, the
non-tagged P and tagged V proteins were not coprecipitated,
indicating that the P protein could not bind directly to the V
protein. Thus, to test the possible homologous interaction
between the V proteins, we did the same assay. As shown in
Fig. 5. Oligomerization of the V protein. (A) Schematic diagram of the Vand P proteins. The asterisks indicate the position of the mutation residues of Trp-motif. The
closed squares indicate the position of the mutation residues of Cys-motif. The arrow above marks the editing site. The shaded box on the P protein indicates the P/V
common domains. The P-specific domain arises due to the insertion of two nontemplated-encoded G residues and is indicated by the open box. Binding with V protein
is summarized on the right panel. (B) Western blot analysis of the proteins from transfected COS cells lysates (input of proteins, left panel) and from
immunoprecipitates using anti-Flag mAb (right panel). Numbers on the top of the figure correspond to the Vand P proteins as described in A. One or two asterisks on
the right indicate the immunoglobulin light or heavy chain, respectively.
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coprecipitated, indicating that the V protein-specific region is
critical for self-association. To identify the amino acid(s)
essential for the self-association, various mutant V proteins
were constructed as illustrated in Fig. 5A. Although all the
polypeptides were successfully expressed in the transfected
cells (Fig. 5B, left panel), only C193/197A V protein was
coprecipitated by anti-Flag mAb (Fig. 5B, right panel, lane 3)
and all other mutant V proteins were not coprecipitated (Fig.
5B, right panel, lanes 2, 4, and 5). These data indicate that the
C-terminal 28 aa on the V-specific region are important for
self-association and that mutation of Trp-motif loses the
function for self-association, suggesting that it alters the
conformation of V protein.
The V and NP proteins of hPIV2 bind with AIP1/Alix
SeV C protein has anti-IFN capacity and binds to a host
protein, AIP1/Alix, that is involved in apoptosis (Sakaguchi et
al., 2005). hPIV2 and SV5 V proteins also have anti-IFN
activity and SV5 V protein is important for blocking apoptosis
(Sun et al., 2004). Therefore, we presumed that AIP1 would
bind to hPIV2 V protein. GST and N-terminally GST-tagged
AIP1 proteins were expressed in E. coli, purified, and
subjected to GST-pulldown assay. The hPIV2-infected cell
lysate was allowed to bind to the glutathione–Sepharose 4B
beads alone (lanes B), Sepharose-immobilized GST (lanes C),
or Sepharose-immobilized GST-AIP1 (lanes D) for 8 h
followed by an analysis of the bound viral proteins by Western
blotting. As shown in Fig. 6A, lanes 4 and 8, the NP and V
proteins were detected in association with GST-AIP1, while theP protein was not. Furthermore, binding between GST-AIP1
and M proteins was not detected by this method (data not
shown). To make sure that no other viral proteins are needed
for these associations, the NP-, P-, or V-expressed cell lysates
were investigated by using similar method. The NP and V
proteins were detected in association with GST-AIP1 without
other viral proteins (Fig. 6B, lanes 4 and 12), while the P
protein was not with/without other viral proteins (Figs. 6A,
lane 8 and B, lane 8).
To identify the domain on the V protein responsible for its
binding to AIP1, various V proteins as illustrated in Fig. 6C
were tested. The V proteins that have mutations in Cys-motif
and Trp-motif could not bind to GST-AIP1 (Fig. 6D). These
data suggest that the V-specific region is important to bind with
AIP1.
The hPIV2 V alters its distribution when coexpressed
transiently with AIP1
The wt V protein was detected exclusively in the nuclei
(Fig. 7A), while the C-terminally HA-tagged AIP1 protein
was detected exclusively in the cytoplasm (Fig. 7B) when
they were expressed transiently. Since the V protein can bind
to AIP1 as described above, we performed cotransfection
experiment in order to see whether the AIP1 would affect the
subcellular distribution of the V protein. The AIP1-HA protein
in the cells expressing only AIP1-HA was found in the
cytoplasm (the left cell, Fig. 7C), and the wt V protein in the
cells expressing only V protein was found in the nuclei (two
cells in the right corner of Fig. 7C). However, the wt V
protein in the cells expressing both the wt V and AIP1-HA
Fig. 6. Analysis of interactions of NP and V proteins with AIP1 by GST-pulldown and Western blot assays. (A) Western blot analysis of the proteins by using anti-NP
(lanes 1–4) or anti-P/V (lanes 5–8) mAb. Lanes A are input of proteins from parent rPIV2-infected Vero (lanes 1 and 5). Lanes B, C, or D are precipitates from GST-
pulldown assay of glutathione–Sepharose 4B beads alone, glutathione S-transferase protein, or GST-AIP1 fusion protein, respectively. (B) Western blot analysis of the
proteins by using anti-NP (lanes 1–4) or anti-P/V (lanes 5–12) mAb. Lanes A are input of proteins from transfected COS (lanes 1, 5, and 9) cells lysates. Lanes B, C, or
D are precipitates from GST-pulldown assay of glutathione–Sepharose 4B beads alone, glutathione S-transferase protein, or GST-AIP1 fusion protein, respectively.
Lanes 1–4, 5–8, and 9–12 are transfected with an expression plasmid for hPIV2 NP, P, or V, respectively. (C) Schematic diagram of the V proteins. The asterisks
indicate the position of the mutation residues of Trp-motif. The closed squares indicate the position of the mutation residues of Cys-motif. The arrow above marks the
editing site. Binding with AIP1 protein is summarized on the right panel. (D) Western blot analysis of the proteins from transfected COS cells lysates (input of proteins,
left panel) and from GST-pulldown precipitates (right panel). Numbers on the top of the figure correspond to the V proteins as described in C.
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7C). On the other hand, the mutant V protein, V-C209/211/
214A, in the cells expressing only mutant V protein was
found in the nuclei like the wt V protein (the cell in the left
corner of Fig. 7D), but the mutant V protein in the cells
expressing both the V and AIP1-HA proteins (arrow pointed)
was kept exclusively in the nuclei (Fig. 7D). Other mutant V
proteins, V-C193/197A, V-C218/221A and V-W178H/W182E,
were also found in the nuclei, even if both the mutant V and
AIP1-HA proteins were expressed in the same cells (data not
shown). When the N-terminally HA-tagged AIP1 was
expressed together with the hPIV2 V protein, we got the
same result to that using AIP1-HA (C-terminally HA-tagged
AIP1) (data not shown).
We then established new cell lines constitutively expressing
both AIP1-HA and hPIV2 V proteins (HeLa/AIP-HA+V). As
shown in Fig. 7E, localization of the AIP1-HA protein in HeLa/AIP-HA+V cells was detected in the cytoplasm but the stably
expressed V protein was detected in the nuclei. Thus, these data
suggested that AIP1 alters the subcellular distribution of the
transiently expressed V protein, but does not that of the stably
expressed V protein. Thus, nuclear localization of the
transiently expressed mutant V proteins seems consistent with
their inability to bind with AIP1.
Suppression of parent virus growth by AIP1 depletion
To investigate possible involvement of AIP1 in hPIV2 virus
growth, we established new cell lines, HeLa-tet/shAIP1-1 or 1-
2, in which were depleted the intracellular AIP1 by using short
hairpin RNA (shRNA) induced by adding Dox as described in
Materials and methods. As shown in Fig. 8A, AIP1-targeted
shRNAs effectively suppressed the expression of HA-tagged
AIP1, indicating that the intrinsic AIP1 was also depleted. By
Fig. 7. Immunofluorescence staining patterns of AIP1-HA and V proteins in transiently or constitutively expressing cells. (A) Subcellular distribution of transiently
expressed wt V protein. HeLa cells were transfected with plasmid encoding wt V protein. Twenty hours posttransfection, the cells were fixed, permeabilized, and
stained with mAb against the V protein. Expressed protein was visualized using TRITC-labeled secondary antibody (red). Nuclei were stained with DAPI (blue). (B)
Subcellular distribution of transiently expressed AIP1-HA protein in HeLa cells. Twenty hours posttransfection, the cells were fixed, permeabilized, and stained with
mAb against the HA epitope. Expressed protein was visualized using FITC-labeled secondary antibody (green). Nuclei were stained with DAPI (blue). (C and D)
Subcellular distribution of transiently expressed AIP1-HA and wt V (C) or mutant V (D) proteins in HeLa cells. Twenty hours posttransfection, the cells were fixed,
permeabilized, and stained with anti-P/V (IgG1) and anti-HA (IgG2a) mAbs. Expressed proteins were visualized using TRITC-labeled IgG1 (red) and FITC-labeled
IgG2a (green) secondary antibodies. The arrows show the cells expressing both AIP1-HA and V proteins. (E) Subcellular distribution of constitutively expressed
AIP1-HA and wt V proteins in HeLa/AIP1-HA+V cells. The cells were fixed, permeabilized, and stained with anti-P/V (IgG1) and anti-HA (IgG2a) mAbs. Expressed
proteins were visualized using TRITC-labeled IgG1 (red) and FITC-labeled IgG2a (green) secondary antibodies.
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tet/shGFP, in which was depleted the GFP protein by adding
Dox, as a negative control. The parent hPIV2 growth in HeLa-
tet/shGFP was unaffected, whereas the growth in HeLa-tet/shAIP1-1 and 1-2 was inhibited by 10- to 100-fold (Fig. 8B).
In contrast, the growth rates of mutant rPIV2s in HeLa-tet/
shAIP1-1 treated with/without Dox were similar (Fig. 8C).
These results have shown that the association between C-
Fig. 8. Virus growth by AIP1 depletion in HeLa-tet/shAIP cells. (A) HeLa-tet/
shGFP or HeLa-tet/shAIP1-1 and 1-2 cell lines were transfected with an
expression plasmid encoding GFP (pCI-GFP) or AIP1-HA (pCI-AIP-HA),
respectively, with/without 5 μg/ml Dox. After 24 h, the cells were assayed by
Western blotting using anti-GFP or HA antibody. Actin was used as a loading
control. (B) Virus growth of parent rPIV2 in HeLa-tet/shGFP, HeLa-tet/shAIP1-
1, and 1-2 cells treated with/without 5 μg/ml Dox at 48 h postinfection. Virus
titers were determined as described in the legend for Fig. 1B. (C) Virus growth
of parent rPIV2, rPIV2-V-W178H/W182E, -C193/197A, or -C209/211/214A in
HeLa-tet/shAIP1-1 cells treated with/without 5 μg/ml Dox at 48 h postinfection.
Virus titers were determined as described in the legend for Fig. 1B.
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growth.
Discussion
Our previous study showed that conserved seven Cys
residues (193, 197, 209, 211, 214, 218, and 221 Cys), Trp-
motif (178, 182, and 192 Trp), 207 Phe of V protein-specific
domain, and 143 Phe of the P/V common domain in the hPIV2
V protein are essential for STAT protein degradation and that
these residues in the V-specific domain are also essential for
promoting virus growth (Nishio et al., 2005b). Recombinant
morbilliviruses (Schneider et al., 1997), respiroviruses (Delenda
et al., 1997; Kato et al., 1997), and NDV (Huang et al., 2003;
Park et al., 2003) that cannot express their V and W proteins
have been recovered and all these viruses grow similarly to the
respective parent virus at least in some cell lines. In the genus
Rubulavirus, recombinant SV5 lacking the C-terminus of theV protein (rSV5ΔC) grows well similar to parent rSV5 in Vero
cells (He et al., 2002). However, the recombinant PIV2s that
have these mutations, C-terminally or fully lacking of V protein,
grow poorly even in the IFN-nonproducing or -unresponsive
cells, such as Vero, U3A, or U6A. Thus, the V protein of hPIV2
is so clearly important for promoting virus growth.
In this report, we first investigated whether the growth rate of
rPIV2s mutant viruses improves in previously established
HeLa-V cells that are constitutively expressing the hPIV2 V
protein (Nishio et al., 2001). HeLa-V cells contained specifi-
cally reduced levels of STAT2, and in these cells, IFN signaling
was blocked. Unexpectedly, the growth of rPIV2s mutant
viruses could not improve in HeLa-V cells. Huang et al. (2003)
reported that transient expression of the carboxyl terminal
portion of the V protein enhanced the growth of the NDV
mutant viruses in which the expression of the V or both the V
and W proteins has been abolished. Thus, we next established a
stable HeLa tet-on cell line in which expression of hPIV2 V
protein was induced by treatment with Dox (HeLa-tet/V). The
virus growth of mutant rPIV2s in HeLa-tet/V cells treated with
Dox improved 10- to 100-fold as many as those in the
nontreated cells. Although the growth of NDV mutant viruses
was similar to that of parent NDVat 24 h after transfection of the
V protein (Huang et al., 2003), the yields of rPIV2s mutant
viruses were still 10- to 20-fold lower than those of parent
rPIV2 and treatment with Dox at 14 h after infection was more
effective than treatment with Dox at the same time with
infection. Thus, to achieve the similar growth level to parent
hPIV2, additional studies including the transient expression at
the appropriate time are necessary. In addition, we investigated
whether the growth of rPIV2s mutant viruses improves by
transiently expressing other rubulavirus V proteins. hPIV2 V
protein shows 69.3, 41.1, and 34.8% homologies with those of
SV41, SV5, and MuV, respectively (Kawano et al., 1993;
Kondo et al., 1990). In these rubulaviruses, only the SV41 V
protein has an ability to promote the growth of rPIV2s mutant
viruses. Though STAT degradation tropism of these V proteins
is different from each other, both V proteins have a common
function to promote virus growth.
In previous studies, we identified essential domains for
interaction between the hPIV2 NP, P, and V proteins (Nishio et
al., 1996, 1997, 1999b; Watanabe et al., 1996b). In these
studies, we demonstrated that aa 1–46 of the P/V common
region on the V protein are required for its binding to the aa
401–493 on the NP protein, and the V protein may form a
complex only with NP0. In the case of SV5, it has been
suggested that the V protein may complete with the P protein for
soluble NP, delaying encapsidation and thus being part of a
controlling mechanism which switches from virus transcription
to replication (Precious et al., 1995). Since the NP and P
proteins of rPIV2s that have mutations in the V-specific region
show some masses-shaped subcellular distribution in the virus-
infected cells, it is predicted that the V-specific region is
important in keeping NP soluble for virus growth. In this study,
we identified that aa 178–225 on the V-specific region are
important to bind to the aa 1–82 on the NP and aa 198–225 on
the V-specific domain are important for V–V oligomerization,
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Therefore, it is supposed that the alteration of the P protein
distribution in the mutant rPIV2-infected cells is due to the
alteration of the distribution of the NP associated with the P
protein. Although V protein oligomerization has been hypothe-
sized to be involved in STAT degradation (Ulane et al., 2005),
biological roles of the oligomerization needed to be established.
The domains on the NP and V proteins identified in this study
and our previous studies are summarized in Fig. 9.
Li et al. (2006) recently reported the crystal structure of
complex of DDB1 and SV5 V proteins. The unique C-terminal
sequence of the SV5 V protein forms the middle two β strands
(β6 and β7) as well as the zinc-binding motif of the core
domain, all of which are crucial structure elements for the V
protein to maintain its unique fold. It binds two zinc ions via
171 His and seven Cys (190, 194, 206, 208, 211, and 218)
residues, all of which are conserved among the V proteins of
paramyxoviruses (Paterson et al., 1995). 171 His and three Cys
(190, 211, and 218) residues fold one zinc ion, and other four
Cys (194, 206, 208, and 211) residues fold another one. From
sequence alignment and structural elements of the V proteins of
SV5 and hPIV2, two Trp residues (178 and 182) of hPIV2 V
protein turned out to locate on the β6 sheet, and 192 Trp on the
β7. Therefore, it is speculated that the mutation of Trp-motif on
the V protein alters the conformation of these β sheets, and the
mutations of Cys-motif alter the novel zinc-finger fold. In this
paper, we tested various mutant V proteins, W178H/W182E,
C193/197A, C209/211/214A, and C218/221A, to identify the
essential amino acids on the V protein for binding to the NP and
its oligomerization. As the V protein that has the W178H/
W182E mutation could not bind to the NP and V proteins, the β
sheets on the V-unique region may be very important for its
structure. Since the V83-225/Δ155–192 (this mutant lacks the
β sheets and 174 His of the zinc-finger fold on the V-unique
region) and the mutant C193/197A (ones of four residues on
each zinc-binding sequence are mutated) still have ability to
bind with the NP, the structural alteration by mutating each one
on zinc-binding residues may be not drastic. However, both of
those β sheets and zinc-finger fold are crucial structure elementsFig. 9. Schematic model of functional domains in the NP and V proteins of hPIV2. T
boxes. Amino acid residues 1–46 on the P/V common region are required for binding
domain are important for binding to the aa 1–82 region on the NP protein and AIP1. C
1–294, 295–400, and 401–493 on the NP protein are required for self-assembly, fo
respectively. The arrow below the letter “G” indicates the editing site.for the V protein, and both of them would be important for its
function.
AIP1 (ALG-2 interacting protein 1)/Alix (ALG-2-interacting
protein X) was previously identified as an interactor for the
apoptosis-linked-gene 2 (ALG-2) protein and as a calcium
binding protein implicated in apoptosis (Missotten et al., 1999;
Vito et al., 1999). AIP1 has also been shown to interact with a
conserved C-terminal region of human immunodeficiency virus
type 1 (HIV-1) p6 and equine infectious anemia virus (EIAV) p9
(Strack et al., 2003). HIV release requires TSG101, a cellular
factor that sorts proteins into vesicles that bud into multi-
vesicular bodies (MVB). The proteins involved in MVB
biogenesis (the class E proteins) were connected into a coherent
network by many different protein–protein interactions, with
AIP1 playing a key role in linking complexes that act early
(TSG101/ESCRT-1) and late (CHMP4/ESCRT-III) in this
pathway. AIP1 interacts specifically with the PT/SAP and
LXXLF motifs of HIV-1, and with the YPXL/I-type L domain
of EIAV. The V-specific region does not contain any of these
motifs required for interaction with AIP1.
Various Gag proteins of retroviruses directly interact to the
ubiquitin ligases of the Nedd4 family, which are involved in the
ubiquitination of membrane-associated proteins to initiate their
sorting toward internal MVB vesicles (Segura-Morales et al.,
2005). Since inhibition of virus budding by the dominant-
negative form of Vsp4A, an AAA-type ATPase essential for
ESCRT function, has been described previously for SV5 and
SeV (Sakaguchi et al., 2005; Schmitt et al., 2005), ESCRT may
be necessary for efficient budding of paramyxovirus. It has been
reported that efficient budding of SV5 virus-like particles
(VLPs) requires expression of the NP, and binding between the
M protein and AIP1 is not detected (Schmitt et al., 2002, 2005).
Since the M protein of hPIV2 binds to the NP (data not shown),
the formation of complex between NP, M, and AIP1 may be
important for formation of hPIV2 virus particles. Previously, it
was shown that the V proteins of SV5 and hPIV2 mediate the
STAT protein degradation and have an E3 ubiquitin ligase
activity (Ulane and Horvath, 2002). E3s (ubiquitin ligases) are
classified into HECT type E3 and RING finger type E3. Nedd4he functional domains identified from this and previous works are indicated by
to the aa 401–493 region on the NP protein. Residues 178–225 on the V-specific
-terminal 28 aa on the V-specific domain is required for self-assembly. Residues
r binding to C-terminal domain of P protein, and for binding to the L protein,
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is critical for STAT protein degradation. Thus, it is estimated
that the V protein may act as ubiqutin ligase for MBV
biogenesis.
The hPIV2 V protein is capable of many protein interactions
both with viral partners, including the NP and viral RNA
(Nishio et al., 2006), and with cellular machinery, like Mda-5
(Andrejeva et al., 2004) or V-dependent degradation complex
components. The conserved carboxyl terminal region (aa 178–
225) of the V protein plays an important role in virus growth.
The mechanism underlying this phenomenon is not clear yet,
but it seems very likely that interactions of the V protein with
NP and/or with AIP1 protein through this region are required for
efficient virus growth. Since this region harbors the V protein
oligomerization domain, the interaction between V proteins
might also be involved. In the cells expressing hPIV2 V protein
constitutively, the V protein localized in the nuclei and did not
show colocalization with AIP1 in the cytoplasm (Fig. 7E), while
these proteins colocalized in the cytoplasm when transiently
transfected (Fig. 7C). It may account for the observation that the
growth of mutant hPIV2s was not improved in HeLa cells
constitutively expressing the V protein. AIP1 depletion by
shRNA resulted in suppression of growth of hPIV2. Further-
more, overexpression of AIP1 enhanced the growth of mutant
hPIV2s (data not shown). Lower growth of mutant rPIV2s may
be due to the inability of its mutated V protein to interact with
AIP1. We also investigated the association between GST-AIP1
and HA-tagged SV41, SV5, or MuV V proteins by the same
method of Fig. 6B. The SV41 and MuV V proteins were
associated with GST-AIP1, while SV5 V protein was not (data
not shown).
SeV lacking C protein has a severe defect in virus growth
(Koyama et al., 2003; Kurotani et al., 1998). The V protein of
SeV inhibits RNA replication, whereas the V protein of SV5
inhibits both RNA replication and transcription (Lin et al.,
2005). The V protein of SV5 plays an important role in blocking
apoptosis (Sun et al., 2004). However, the V proteins of hPIV2,
SV5, and SeV and the C protein of SeV are not necessary for
recovery of recombinant virus from transfected cDNA clones,
though recovery rate of rPIV2 without V protein was very low.
At present, it is not clear yet whether the complex of the V, NP,
and AIP1 proteins is related to virus budding. Additional studies
are required to fully assess the role of the V protein.
Materials and methods
Cells and viruses
HeLa, Vero, COS, human 2fTGH cells, and 2fGH-derived
cell lines U3A (STAT1 deficient) and U6A (STAT2 deficient)
(gift from Dr. I. M. Kerr, Imperial Cancer Research Fund,
London, United Kingdom) were grown in Eagle's minimal
essential medium (MEM) supplemented with 10% fetal calf
serum (FCS). HeLa-V cells, HeLa cell line constitutively
expressing the hPIV2 V protein (Nishio et al., 2001), were
cultured in Eagle's MEM supplemented with 10% FCS and
1 mg/ml G418 (Geneticin; GIBCO). T-Rex-HeLa cells expres-sing the Tet-operator were purchased from Invitrogen and
cultured according to the manufacturer's instructions. Recom-
binant human parainfluenza type virus 2 (rPIV2) and various
mutant rPIV2, rPIV2-V-W178H/W182E, rPIV2-V-C193/197A,
rPIV2-V-C209/211/214A, and rPIV2-V-C218A (Nishio et al.,
2005b), were used in this study.
Antibodies
Anti-Flag monoclonal antibody (mAb) was purchased from
Sigma (St. Louis, MO). Antibody to GFP (sc-8334) and mAb to
actin (sc-8432) and to HA (sc-7392, IgG2a) were purchased
from Santa Cruz Biotechnology (Santa Cruz, CA.). mAbs
against hPIV2 NP protein (366-1 (reacts with N-terminal 100
aa), 20A (reacts with 308–399 aa), and 159-1 (reacts with C-
terminal 50 aa)), against P/V protein (85A, IgG1), and against V
protein (53-1V) were previously reported (Nishio et al., 1997,
1999a, 1999b).
Construction of expression plasmids
HPIV2 V gene and hPIV2, SV41, SV5, and MuV V genes
fused to N-terminal hemagglutinin (HA) epitope tag were
cloned into pcDNA5/TO vector (Invitrogen). Various calmo-
dulin-binding peptide (CBP) fusion protein expression plasmids
have been described previously (Nishio et al., 2006). A cDNA
fragment encoding the hPIV2 NP, P, V deleted NP, or V mutant
was inserted into the plasmid expression vector pcDL-SRα296,
as described previously (Nishio et al., 1996, 1997, 2006; Takebe
et al., 1988). Flag-tagged hPIV2 V protein expression plasmid
has been described previously (Nishio et al., 2005a). The full-
length cDNA clone of AIP1/Alix (GeneBank accession
numbers NM 013374) was subcloned into pCI-neo vector
(Promega) with a HA tag at the C-terminus (pCI-AIP-HA). For
glutathione S-transferase (GST)-AIP1 fusion protein, the cDNA
of the AIP1 protein was subcloned into pGEX-5X (Pharmacia).
All constructs were confirmed by nucleic acid sequencing.
Establishment of the Doxycycline (Dox)-inducible hPIV2 V or
HA-tagged V HeLa cell lines
To obtain the Dox (Clontech)-inducible V cell lines, T-Rex-
HeLa cells were transfected with the pcDNA5/TO-based
constructs by using FuGENE 6 (Roche) according to the
manufacturer's instructions. At 2 days after transfection, the
culture media were changed to MEM containing 10% FCS,
200 μg/ml hygromycin (Invitrogen), 5 μg/ml blasticidin
(Funakoshi, Japan), and 0.2% agarose, and the cells were
cultured for 3 weeks. Five independent clones that stably
exhibited high expression levels were analyzed. The Tet-on
hPIV2 V cell line (HeLa-tet/V), the Tet-on HA-tagged hPIV2 V
cell line (HeLa-tet/HA-PIV2V), the Tet-on HA-tagged SV5 V
cell line (HeLa-tet/HA-SV5V), the Tet-on HA-tagged SV41 V
cell line (HeLa-tet/HA-SV41V), and the Tet-on HA-tagged
mumps virus V cell line (HeLa-tet/HA-MuV) were maintained
in Eagle's MEM supplemented with 10% FCS, 100 μg/ml
hygromycin, and 5 μg/ml blasticidin.
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V and AIP1-HA proteins
To obtain cell lines expressing both hPIV2 V and AIP1-HA
proteins, HeLa cells were transfected with the plasmids, pDS-V
and pCI-AIP-HA, by using FuGENE 6 according to the
manufacturer's instructions. At 2 days after transfection, the
culture media were changed to MEM containing 10% FCS,
1 mg/ml G418, and 0.2% agarose, and the cells were cultured
for 3 weeks. Five independent clones that exhibited high
expression levels were analyzed. The HeLa/AIP-HA+V cell
line was maintained in Eagle's MEM supplemented with 10%
FCS and 1 mg/ml G418.
Viral growth kinetics
Various monolayer cells were infected with viruses at a
multiplicity of infection (MOI) of about 0.1 and incubated at
37 °C in MEM with 2% FCS. Supernatants were harvested at
appropriate intervals, and virus titers were determined by CPE
method using Vero cells and expressed as 50% tissue culture
infectious dose (TCID50) at 3 days postinfection.
Immunofluorescence staining
The cells were fixed with 3% paraformaldehyde for 30 min
at room temperature and rinsed twice with phosphate-buffered
saline (PBS). The cells were permeabilized with PBS–0.05%
Tween-20 (PBS-T) for 30 min and washed twice with PBS. The
cells were then incubated for 60 min with primary antibody and
washed three times with PBS. Next, the cells were incubated for
60 min with the appropriate secondary antibodies [TRITC-
labeled goat anti-mouse IgG1 and FITC-labeled rat anti-mouse
IgG2a (Southern Biotechnology Associates Inc.)] and washed
with PBS. Immunofluorescently stained cells were analyzed
using a fluorescence microscope.
Purification of bacterially expressed proteins
Bacterially expressed CBP fusion proteins were purified by
the method similar to that described previously (Nishio et al.,
1999a). AIP1 protein was expressed in Escherichia coli BL21
cells as GST fusion protein under isopropyl-1-thio-β-D-
galactopyranoside induction. The GST and GST-AIP1 fusion
proteins were purified from bacteria by using glutathione–
Sepharose beads (Amersham Biosciences, Inc.) according to the
manufacturer's instructions.
Cell extraction, immunoblotting, immunoprecipitation, and
GST-pulldown assay
For preparation of cell extracts, cells were lysed in lysis
buffer (50 mM Tris–HCl (pH 7.5), 40 mM NaCl, 0.6% NP40,
and 4 mM phenylmethylsulfonyl fluoride). For immunoblot-
ting, cell extracts were separated by SDS–PAGE, transferred
to a nitrocellulose membrane, and analyzed by a Western blot
technique with appropriate antibodies as described previously(Nishio et al., 2002). For immunoprecipitation of Flag epitope-
tagged proteins, cell extracts were incubated with an anti-Flag
M2 agarose affinity gel (Sigma, St. Louis, MO) for 6 h at
room temperature. The agarose beads were washed three times
with lysis buffer and then extracted with SDS–PAGE sample
buffer for analysis by a Western blotting technique with
appropriate antibodies. For GST-pulldown assay, whole-cell
extracts were incubated with purified GST or GST-AIP1
fusion protein–agarose beads in IP buffer (50 mM Tris–HCl
(pH 7.5), 5 mM EDTA, 1% Triton X-100, and 4 mM
phenylmethylsulfonyl fluoride) for 8 h and then washed five
times with IP buffer. Bound proteins were eluted by boiling in
protein gel loading buffer and separated by SDS–PAGE for
Western blotting.
Depletion of AIP1/Alix by expressing short hairpin RNA
(shRNA) in Dox-inducible manner
Two DNA fragments encoding shRNA against AIP1/Alix were
generated by PCR and subcloned into the pH1dTO vector (Takei et
al., 2006). pH1dTO-shAIP1-1 and pH1dTO-shAIP1-2, which
target nucleotides 1988-GAATTACTGCAACGAAAT-2005 and
2429-GCTCAAGATGGTGTGATAAAT-2449, respectively, were
constructed, and pH1dTO-shGFP, which targets to the green
fluorescent protein (GFP) transcript, was constructed as a negative
control. To obtain the Dox-inducible shRNA cell lines, T-Rex-
HeLa cells were transfected with the pH1dTO-shAIP1-1,
pH1dTO-shAIP1-2, or pH1dTO-shGFP with a Linear Hygro-
mysin Maker™ (Clontech) by using FuGENE 6 as described
above. To assess the depletion of AIP1/Alix or GFP, HeLa-tet/
shAIP1-1, HeLa-tet/shAIP1-2, or HeLa-tet/shGFP cells were
transfected with the expression plasmid for AIP1-HA (pCI-AIP-
HA) or GFP (pCI-GFP) with/without 5 μg/ml Dox. Two
independent clones for each construct that exhibited most efficient
knockdown were analyzed.
Acknowledgments
This study was supported in part by a Grant-in-aid for
Scientific Research from the Ministry of Education, Science,
Culture, Sports, and Technology of Japan.References
Andrejeva, J., Poole, E., Young, D.F., Goodbourn, S., Randall, R.E., 2002. The
p127 subunit (DDB1) of the UV-DNA damage repair binding protein is
essential for the targeted degradation of STAT1 by the V protein of the
paramyxovirus simian virus 5. J. Virol. 76, 11379–11386.
Andrejeva, J., Childs, K.S., Young, D.F., Carlos, T.S., Stock, N., Goodbourn, S.,
Randall, R.E., 2004. The V proteins of paramyxoviruses bind the IFN-
inducible RNA helicase, mda-5, and inhibit its activation of the IFN-β
promoter. Proc. Natl. Acad. Sci. U. S. A. 101, 17264–17269.
Delenda, C., Hausmann, S., Garcin, D., Kolalofsky, D., 1997. Normal cellular
replication of Sendai virus without the trans-frame, nonstructural V protein.
Virology 228, 55–62.
Didcock, L., Young, D.F., Goodbourn, S., Randall, R.E., 1999a. Sendai virus
and simian virus 5 block activation of interferon-responsive genes:
importance for virus pathogenesis. J. Virol. 73, 3125–3133.
Didcock, L., Young, D.F., Goodbourn, S., Randall, R.E., 1999b. The V protein
97M. Nishio et al. / Virology 362 (2007) 85–98of simian virus 5 inhibits interferon signaling by targeting STAT1 for
protease-mediated degradation. J. Virol. 73, 9928–9933.
Garcin, D., Latorre, P., Kolakofsky, D., 1999. Sendai virus C proteins
counteract the interferon-mediated induction of an antiviral state. J. Virol.
73, 6559–6565.
Garcin, D., Curran, J., Kolakofsky, D., 2000. Sendai virus C proteins must
interact directly with cellular components to interfere with interferon action.
J. Virol. 74, 8823–8830.
Garcin, D., Marq, J.B., Strahle, L., Le Mercier, P., Kolakofsky, D., 2002. All
four Sendai virus C proteins bind Stat1, but only the larger forms also induce
its mono-ubiquitination and degradation. Virology 295, 256–265.
Gotoh, B., Takeuchi, K., Komatsu, T., Yokoo, J., Kimura, Y., Kurotani, A., Kato,
A., Nagai, Y., 1999. Knockout of the Sendai virus C gene eliminates the viral
ability to prevent the interferon-alpha/beta-mediated responses. FEBS Lett.
459, 205–210.
Gotoh, B., Takeuchi, K., Komatsu, T., Yokoo, J., 2003. The STAT2 activation
process is a crucial target of Sendai virus C protein for the blockade of alpha
interferon signaling. J. Virol. 77, 3360–3370.
He, B., Paterson, R.G., Stock, N., Durbin, J.E., Durbin, R.K., Goodbourn, S.,
Randall, R.E., Lamb, R.A., 2002. Recovery of paramyxovirus simian virus 5
with a V protein lacking the conserved cysteine-rich domain: the
multifunctional V protein blocks both interferon-beta induction and
interferon signaling. Virology 303, 15–32.
Horikami, A.M., Smallwood, S., Moyer, S.A., 1996. The Sendai virus V protein
interacts with the NP protein to regulate viral genome RNA replication.
Virology 222, 383–390.
Huang, Z., Krishnamurthy, S., Panda, A., Samal, S.K., 2003. Newcastle disease
virus V protein is associated with viral pathogenesis and functions as an
alpha interferon antagonist. J. Virol. 77, 8676–8685.
Kato, A., Kiyotani, K., Sakai, Y., Yoshida, T., Nagai, Y., 1997. The
paramyxovirus Sendai virus V protein encodes a luxury function required
for virus pathogenesis. EMBO J. 16, 578–587.
Kato, A., Ohnishi, Y., Kohase, M., Saito, S., Tashiro, M., Nagai, Y., 2001. Y2
the smallest of the Sendai virus C proteins, is fully capable of both
counteracting the antiviral action of interferons and inhibiting virus RNA
synthesis. J. Virol. 75, 3802–3810.
Kawano, M., Tsurudome, M., Oki, N., Nishio, M., Komada, H., Matsumura, H.,
Kusagawa, S., Ohta, H., Ito, Y., 1993. Sequence determination of the P gene
of simian virus 41: presence of irregular deletions near the RNA-editing sites
of paramyxoviruses. J. Gen. Virol. 74, 911–916.
Kawano, M., Kaito, M., Kozuka, Y., Komada, H., Noda, N., Nanba, K.,
Tsurudome, M., Ito, M., Nishio, M., Ito, Y., 2001. Recovery of infectious
human parainfluenza type 2 virus from cDNA clones and properties of the
defective virus without V-specific cysteine-rich domain. Virology 284, 99–112.
Komatsu, T., Takeuchi, K., Yokoo, Y., Gotoh, B., 2000. Sendai virus
blocks alpha interferon signaling to signal transducers and activators of
transcription. J. Virol. 74, 2477–2480.
Kondo, K., Bando, H., Tsurudome, M., Kawano, M., Nishio, M., Ito, Y., 1990.
Sequence analysis of the phosphoprotein (P) genes of human parainfluenza
type 4A and 4B viruses and RNA editing at transcript of the P genes: the
number of G residues added is imprecise. Virology 178, 321–326.
Koyama, A.H., Irie, H., Kato, A., Nagai, Y., Adachi, A., 2003. Virus
multiplication and induction of apoptosis by Sendai virus: role of the C
proteins. Microbes Infect. 5 (5), 373–378.
Kubota, T., Yokosawa, N., Yokota, S., Fujii, N., 2001. C terminal CYS-RICH
region of mumps virus structural V protein correlates with block of
interferon alpha and gamma signal transduction pathway through decrease
of STAT 1-alpha. Biochem. Biophys. Res. Commun. 283, 255–259.
Kurotani, A., Kiyotani, K., Kato, A., Shioda, T., Sakai, Y., Mizumoto, K.,
Yoshida, T., Nagai, Y., 1998. Sendai virus C proteins are categorically
nonessential gene products but silencing their expression severely impairs
viral replication and pathogenesis. Genes Cells 3, 111–124.
Lamb, R.A., Kolakofsky, D., 2001. Paramyxoviridae: the viruses and their
replication, In: Fields, B., Knipe, D., Howley, P. (Eds.), Virology, 4th ed.
Lippincott-Raven Publishers.
Leung, S., Qureshi, S.A., Kerr, I.M., Darnell Jr., J.E., Stark, G.R., 1995. Role of
STAT2 in the alpha interferon signaling pathway. Mol. Cell. Biol. 15,
1312–1317.Li, T., Chen, X., Garbutt, K.C., Zhou, P., Zheng, N., 2006. Structure of
DDB1 in complex with a paramyxovirus V protein: viral hijack of a
propeller cluster in ubiquitin ligase. Cell 124, 105–117.
Lin, G.Y., Paterson, R.G., Richardson, C.D., Lamb, R.A., 1998. The V protein
of the paramyxovirus SV5 interacts with damage-specific DNA binding
protein. Virology 249, 189–200.
Lin, Y., Horvath, F., Aligo, J.A., Wilson, R., He, B., 2005. The role of simian
virus 5 V protein on viral RNA synthesis. Virology 338, 270–280.
Malur, A.G., Chattopadhyay, S., Maitra, R.K., Banerjee, A.K., 2005. Inhibition
of STAT1 phosphorylation by human parainfluenza virus type 3 C protein.
J. Virol. 79, 7877–7882.
McKendry, R., John, J., Flavell, D., Muller, M., Kerr, I.M., Stark, G.R., 1991.
High-frequency mutagenesis of human cells and characterization of a mutant
unresponsive to both alpha and gamma interferons. Proc. Natl. Acad. Sci.
U.S.A. 88, 11455–11459.
Mebatsion, T., Verstegen, S., De Veen, L.T.C., Romer-Oberdorfer, A., Schrier,
C.C., 2001. A recombinant Newcastle disease virus with low-level V protein
expression is immunogenic and lacks pathogenicity for chicken embryos.
J. Virol. 75, 420–428.
Missotten, M., Nichols, A., Rieger, K., Sadoul, R., 1999. Alix, a novel mouse
protein undergoing calcium-dependent interaction with the apoptosis-
linked-gene-2 (ALG-2) protein. Cell Death Differ. 6, 124–129.
Muller, M., Laxton, C., Briscoe, J., Schindler, C., Improta, T., Darnell Jr., J.E.,
Stark, G.R., Kerr, I.M., 1993. Complementation of a mutant cell line: central
role of the 91-kDa polypeptide of ISGF3 in the interferon-α and γ signal
transduction pathway. EMBO J. 12, 4221–4228.
Nishio, M., Tsurudome, M., Kawano, M., Watanabe, N., Ohgimoto, S., Ito, M.,
Komada, H., Ito, Y., 1996. Interaction between nucleocapsid protein (NP)
and phosphoprotein (P) of human parainfluenza virus type 2: one of the two
NP binding sites on P is essential for granule formation. J. Gen. Virol. 77,
2457–2463.
Nishio, M., Tsurudome, M., Ito, M., Watanabe, N., Kawano, M., Komada, H.,
Ito, Y., 1997. Human parainfluenza virus type 2 phosphoprotein: mapping of
monoclonal antibody epitopes and location of the multimerization domain.
J. Gen. Virol. 77, 2457–2463.
Nishio, M., Tsurudome, M., Ito, M., Kawano, M., Kusagawa, S., Komada, H.,
Ito, Y., 1999a. Isolation of monoclonal antibodies directed against the V
protein of human parainfluenza virus type 2 and localization of the V protein
in virus-infected cells. Med. Microbiol. Immunol. 188, 79–82.
Nishio, M., Tsurudome, M., Ito, M., Kawano, M., Kusagawa, S., Komada, H.,
Ito, Y., 1999b. Mapping of domains on the human parainfluenza virus type 2
nucleocapsid protein (NP) required for NP–phosphoprotein or NP–NP
interaction. J. Gen. Virol. 80, 2017–2022.
Nishio, M., Tsurudome, M., Ito, M., Kawano, M., Komada, H., Ito, Y., 2001.
High resistance of human parainfluenza type 2 virus protein-expressing cells
to the antiviral and anti-cell proliferative activities of alpha/beta interferons:
cysteine-rich V-specific domain is required for high resistance to the
interferons. J. Virol. 75, 9165–9176.
Nishio, M., Garcin, D., Simonet, V., Kolakofsky, D., 2002. The carboxyl
segment of the mumps virus V protein associates with Stat proteins in vitro
via a tryptophan-rich motif. Virology 300, 92–99.
Nishio, M., Tsurudome, M., Ito, M., Ito, Y., 2005a. Human parainfluenza virus
type 4 is incapable of evading the interferon-induced antiviral effect. J. Virol.
79, 14756–14768.
Nishio, M., Tsurudome, M., Ito, M., Garcin, D., Kolakofsky, D., Ito, Y., 2005b.
Identification of paramyxovirus V protein residues essential for STAT pro-
tein degradation and promotion of virus replication. J. Virol. 79, 8591–8601.
Nishio, M., Tsurudome, M., Ito, M., Ito, Y., 2006. Identification of RNA-
binding regions on the P and V proteins of human parainfluenza virus type 2.
Med. Microbiol. Immunol. 195, 29–36.
Ohgimoto, S., Bando, H., Kawano, M., Okamoto, K., Kondo, K., Tsurudome,
M., Nishio, M., Ito, Y., 1990. Sequence analysis of P gene of human
parainfluenza type 2 virus: P and cysteine-rich proteins are translated by two
mRNAs that differ by two nontemplated G residues. Virology 177,
116–123.
Palosaari, H., Parisien, J.-P., Rodriguez, J.J., Ulane, C.M., Horvath, C.M., 2003.
STAT protein interference and suppression of cytokine signal transduction
by measles virus V protein. J. Virol. 77, 7635–7644.
98 M. Nishio et al. / Virology 362 (2007) 85–98Parisien, J.-P., Lau, J.F., Rodriguez, J.J., Sullivan, B.M., Moscona, A., Parks,
G.D., Lamb, R.A., Horvath, C.M., 2001. The V protein of human
parainfluenza virus 2 antagonizes type I interferon responses by destabilizing
signal transducer and activator of transcription 2. Virology 283, 230–239.
Park, M.S., Garcia-Sastre, A., Cros, J.F., Basler, C.F., Palese, P., 2003.
Newcastle disease virus V protein is a determinant of host range restriction.
J. Virol. 77, 9522–9532.
Paterson, R.G., Leser, G.P., Shqughnessy, M.A., Lamb, R.A., 1995. The
paramyxovirus SV5 V protein binds two atoms of zinc and is a structural
component of virions. Virology 208, 121–131.
Pellegrini, S., Joh, J., Shearer, M., Kerr, I.M., Stark, G.R., 1989. Use of a
selectable marker regulated by alpha interferon to obtain mutations in the
signaling pathway. Mol. Cell. Biol. 9, 4605–4612.
Precious, B., Young, D.F., Bermingham, A., Fearns, R., Ryan, M., Randall,
R.E., 1995. Inducible expression of the, P, V and NP genes of the
paramyxovirus SV5 in cell-lines and an examination of NP:P and NP:V
interactions. J. Virol. 69, 8001–8010.
Randall, R.E., Bermingham, A., 1996. NP:P and NP:V interactions of the
paramyxovirus simian virus 5 examined using a novel protein:protein
capture assay. Virology 224, 121–129.
Rodriguez, J.J., Parisien, J.–P., Horvath, C.M., 2002. Nipah virus V protein
evades alpha and gamma interferons by preventing STAT1 and STAT2
activation and nuclear accumulation. J. Virol. 76, 11476–11483.
Rodriguez, J.J., Wang, L.F., Horvath, C.M., 2003. Hendra virus V protein
inhibits interferon signaling by preventing STAT1 and STAT2 nuclear
accumulation. J. Virol. 77, 11842–11845.
Sakaguchi, T., Kato, A., Sugahara, F., Shimazu, Y., Inoue, M., Kiyotani, K.,
Nagai, Y., Yoshida, T., 2005. AIP1/Alix is a binding partner of Sendai virus
C protein and facilitates virus budding. J. Virol. 79, 8933–8941.
Schmitt, A., Leser, G.P., Waning, D.L., Lamb, R.A., 2002. Requirements for
budding of paramyxovirus simian virus 5 virus-like particles. J. Virol. 76,
3952–3964.
Schmitt, A., Leser, G.P., Morita, E., Sundquist, W.I., Lamb, R.A., 2005.
Evidence for a new viral late-domain core sequence, FPIV, necessary for
budding of a paramyxovirus. J. Virol. 79, 2988–2997.
Schneider, H., Kaelin, K., Billeter, M.A., 1997. Recombinant measles viruses
defective for RNA editing and V protein synthesis are viable in cultured
cells. Virology 227, 314–322.
Segura-Morales, C., Pescia, C., Chatellard-Casse, C., Sadoul, R., Bertrand, E.,
Basyuk, E., 2005. Tsg101 and Alix interact with murine leukemia virus gag
and cooperate with Nedd4 ubiquitin ligases during budding. J. Biol. Chem.
280, 27004–27012.
Strack, B., Calistri, A., Craig, S., Popova, E., Gottlinger, H.G., 2003. AIP1/Alix
is a binding partner for HIV-1 p6 and EIV p9 functioning in virus budding.
Cell 114, 689–699.
Sun, M., Rothermel, T.A., Shuman, L., Aligo, J.A., Xu, S., Lin, Y., Lamb, R.A.,
He, B., 2004. Conserved cysteine-rich domain of paramyxovirus simian
virus 5 V protein plays an important role in blocking apoptosis. J. Virol. 78,
5068–5078.Takebe, Y., Seiki, M., Fujisawa, J., Hoy, P., Yokota, K., Arai, K., Yoshida, M.,
Arai, N., 1988. SR promoter: an efficient and versatile mammalian cDNA
expression system composed of the simian virus 40 early promoter and the
R-U5 segment of the human T-cell leukemia virus type 1 long terminal
repeat. Mol. Cell. Biol. 8, 466–472.
Takei, D., Ishihara, H., Yamaguchi, S., Yamada, T., Tamura, A., Maruyama, Y.,
Oka, Y., 2006. WFS1 protein modulates the free Ca2+ concentration in the
endoplasmic reticulum. FEBS Lett. 580, 5635–5640.
Takeuchi, K., Tanabayashi, K., Hishiyama, M., Yamada, Y., Yamada, A.,
Sugiura, A., 1990. Determination and characterization of mumps virus V
protein. Virology 178, 247–253.
Takeuchi, K., Komatsu, T., Yokoo, J., Kato, A., Shioda, T., Nagai, Y., Gotoh, B.,
2001. Sendai virus C protein physically associates with Stat1. Genes cells 6,
545–557.
Takeuchi, K., Kadota, S.I., Takeda, M., Miyajima, N., Nagata, K., 2003.
Measles virus V protein blocks interferon (IFN)-alpha/beta but not IFN-
gamma signaling by inhibiting STAT1 and STAT2 phosphorylation. FEBS
Lett. 545, 177–182.
Ulane, C.M., Horvath, C.M., 2002. Paramyxoviruses SV5 and HPIV2 assemble
STAT protein ubiquitin ligase complexes from cellular components.
Virology 304, 160–166.
Ulane, C.M., Rodriguez, J.J., Parisien, J.-P., Horvath, C.M., 2003. STAT3
ubiquitylation and degradation by mumps virus suppress cytokine and
oncogene signaling. J. Virol. 77, 6385–6393.
Ulane, C.M., Kentsis, A., Cruz, C.D., Parisien, J.-P., Schneider, K., Horvath,
C.M., 2005. Composition and assembly of STAT-targeting ubiquitin ligase
complex: paramyxovirus V protein carboxyl terminus is an oligomerization
domain. J. Virol. 79, 10180–10189.
Valsamakis, A., Schneider, H., Auwaerter, P.G., Kaneshima, H., Billeter, M.A.,
Griffin, D.G., 1998. Recombinant measles viruses with mutations in the C,
V, or F gene have altered growth phenotypes in vivo. J. Virol. 72,
7754–7761.
Vito, P., Pellegrini, L., Guiet, C., D'Adamio, L., 1999. Cloning of AIP1, a novel
protein that associates with the apoptosis-linked gene ALG-2 in a Ca2+-
dependent reaction. J. Biol. Chem. 274, 1533–1540.
Watanabe, N., Kawano, M., Tsurudome, M., Kusagawa, S., Nishio, M.,
Komada, H., Shima, T., Ito, Y., 1996a. Identification of the sequences
responsible for nuclear targeting of the V protein of human parainfluenza
type 2 virus. J. Gen.Virol. 77, 327–338.
Watanabe, N., Kawano, M., Tsurudome, M., Nishio, M., Ito, M., Ohgimoto, S.,
Suga, S., Komada, H., Ito, Y., 1996b. Binding of the V proteins to the
nucleocapsid proteins of human parainfluenza type 2 virus. Med. Microbiol.
Immunol. 185, 89–94.
Yokosawa, N., Yokota, S., Kubota, T., Fujii, N., 2002. C-terminal region of
STAT-1α is not necessary for its ubiquitination and degradation caused by
mumps virus V protein. J. Virol. 76, 12683–12690.
Young, D.F., Didcock, L., Goodbourn, S., Randall, R.E., 2000. Paramyxoviridae
use distinct virus-specific mechanisms to circumvent the interferon
response. Virology 269, 383–390.
